Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Lancet Psychiatry. 2017 Jan 19;4(4):320–329. doi: 10.1016/S2215-0366(16)30377-7

Table 1.

Associations supported by meta-analytic evidence

Antecedent Outcomes Meta-analytic support
PTSD CVD events
Incident CHD HR= 1.55 (95% CI 1.34–1.79); with adjustment for depression, HR= 1.27 (95% CI 1.08–1.49)
Edmondson et al., 2013
Incident stroke/TIA RR= 2.36 (95% CI 2.11–2.65)
Emdin et al., 2016
Incident VTE No
Recurrent MI/unstable angina/mortality RR= 2.0 (95% CI, 1.69–2.37)
Edmondson et al., 2013
Recurrent stroke/TIA No
Mechanisms
Type 2 diabetes RR = 1.49, 95% CI = 1.17–1.89)
Vancampfort et al., 2016
Metabolic syndrome OR= RR = 1.82; 95% CI = 1.72 –.92
Rosenbaum et al., 2015
Blood pressure Systolic; Unweighted d (SE)= .13 (.07)
Diastolic; Unweighted d (SE) = .39 (.21)
Buckley et al., 2001
Inflammation Greater IL-1β, IL-6, and interferon γ in PTSD
Passos et al., 2015
Cortisol Unclear
Klassens et al., 2012; Morris et al., 2012
Endothelial dysfunction No
Obesity OR = 1.35 (95% CI 1.05–1.74)
Bartoli et al., 2015
Smoking 6/7 studies showed positive associations; ORs ranged 2.04–4.52
Fu et al., 2007
Sleep No
Medication nonadherence No
ACS PTSD 12% screen positive (95% CI, 9%–16%)
Edmondson et al., 2013
Stroke/TIA 23% screen positive (95% CI, 16–33%)
Edmondson et. al., 2013
VTE No